Associated Papers
Deep Sequencing Reveals Novel Mutations in Androgen Receptor-Related Genes in Prostate Cancer.
Pedroza-Torres A et al.
International Journal of Molecular Sciences, 2025
Feasibility of long-read sequencing to identify molecular alterations in an Indonesian cohort of locally advanced to advanced nasopharyngeal cancer.
Handoko et al.
Scientific Reports, 2025
Molecular insights into TP53 mutation (p. Arg267Trp) and its connection to Choroid Plexus Carcinomas and Li-Fraumeni Syndrome.
Abduljaleel Z
Genes & Genomics, 2024
Genetic Profiling of Sebaceous Carcinoma Arising from an Ovarian Mature Teratoma: A Case Report.
Zaitsu S et al.
International Journal of Molecular Sciences, 2024
TP53 germline pathogenic variants in modern humans were likely originated during recent human history.
Kou SH et al.
Nar Cancer, 2023
Mutational landscape of gastric adenocarcinoma in Latin America: A genetic approach for precision medicine.
Cerrato-Izaguirre D et al.
Genes & Diseases, 2022
Genetic Susceptibility in Understanding of Pancreatic Ductal Adenocarcinoma Risk: A Decade-Long Effort of the PANDORA Consortium.
Vodickova L et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2022
Molecular characterization of colorectal cancer patients
Afanador CH et al.
Biomedica : Revista Del Instituto Nacional De Salud, 2022
Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene.
Doffe F et al.
Cell Death and Differentiation, 2021
Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population.
Rogoża-Janiszewska E et al.
Breast Cancer (tokyo, Japan), 2021
Pattern of nucleotide variants of TP53 and their correlation with the expression of p53 and its downstream proteins in a Sri Lankan cohort of breast and colorectal cancer patients.
Manoharan V et al.
Bmc Cancer, 2020
Nucleotide variants and protein expression of TP53 in a Sri Lankan cohort of patients with head and neck cancer.
Manoharan V et al.
Molecular Medicine Reports, 2019
Five P53 SNPs Involved in Low Rectal Cancer Risk and Prognosis in a Chinese Population.
Zhang G et al.
Journal of Cancer, 2019
TP53 Mutation Status of Tubo-ovarian and Peritoneal High-grade Serous Carcinoma with a Wild-type p53 Immunostaining Pattern.
Na K et al.
Anticancer Research, 2017
Low Variability and Stable Frequency of Common Haplotypes of the TP53 Gene Region in Colorectal Cancer Patients in a Slovak Population.
Škereňová M et al.
Anticancer Research, 2017
Germline TP53 mutational spectrum in French Canadians with breast cancer.
Arcand SL et al.
Bmc Medical Genetics, 2015
Genotype and Haplotype Analyses of TP53 Gene in Breast Cancer Patients: Association with Risk and Clinical Outcomes.
Vymetalkova V et al.
Plos One, 2015
Detection of p53 common intron polymorphisms in patients with gastritis lesions from Iran.
Najjar Sadeghi R et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2013
Association of intron and exon polymorphisms of p53 gene in Iranian patients with gastritis.
Najjar Sadeghi R et al.
Gastroenterology and Hepatology From Bed to Bench, 2013
A single-nucleotide polymorphism in TP53 may be a genetic risk factor for Iranian patients with idiopathic male infertility.
Mashayekhi F et al.
Andrologia, 2012
Genotype and haplotype analysis of TP53 gene and the risk of pancreatic cancer: an association study in the Czech Republic.
Naccarati A et al.
Carcinogenesis, 2010
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier M et al.
Cold Spring Harbor Perspectives in Biology, 2010
Lack of association between polymorphisms in p53 gene and spermatogenetic failure in a Chinese population.
Lu NX et al.
Andrologia, 2007
Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population.
Yamada H et al.
Carcinogenesis, 2007